Searched for
IMMUNE ONCOLOGY DRUG
Scanning cancer, up close & personal: A revolution is underway in cancer diagnosis- Avammune’s big bet: Why the future of cancer treatment may come in a pill
- Could space-grown stem cells unlock faster cancer treatments and revolutionize organ regeneration breakthroughs? NASA’s ISS experiments are revealing surprising answers about the power of microgravity medicine
- Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...10 May, 2026, 08.50 AM IST
- Dr Reddy’s, Alvotech to co-develop Keytruda biosimilarDr. Reddy's Laboratories and Alvotech are collaborating to develop, manufacture, and commercialize a biosimilar version of Keytruda, a high...06 Jun, 2025, 10.55 AM IST
- Dr Reddy's Laboratories shares rise 2% after launching drug to treat nasopharyngeal cancerDr Reddy's Laboratories has launched toripalimab, an immune oncology drug for adults with recurrent or metastatic nasopharyngeal carcinoma ...29 Nov, 2024, 10.15 AM IST
- Dr Reddy's launches drug for neck, head cancerDr Reddy's Laboratories launched toripalimab, an immune oncology drug for adults with a rare form of head and neck cancer, in India. This d...28 Nov, 2024, 11.00 PM IST
- Aurigene reports promising phase-1 data for its CAR-T therapy against myelomaAurigene Oncology has announced promising phase-1 results for its novel CAR-T cell therapy, Ribrecabtagene autoleucel, in patients with mul...08 Oct, 2024, 04.56 PM IST
- Aurigene inks drug discovery, development pact with US-based EQRxUnder the terms of the collaboration agreement, Aurigene and EQRx will collaborate on drug discovery, pre-clinical and clinical development...04 Jul, 2022, 03.21 PM IST
- New immunotherapy for lung cancer may be effective, safe: LancetNew York, April 8 (IANS) A novel immunotherapy combination is effective and safe at controlling the progression of lung cancer, results fro...08 Apr, 2018, 07.02 PM IST
- MSD launches blockbuster cancer drug Keytruda in IndiaDCGI gave MSD permission to market Keytruda in June 2016, according to minutes of the regulator’s Subject Expert Committee on oncology and ...13 Sep, 2017, 01.43 PM IST
- Gilead to buy Kite for $11.9 billion in cancer drug megadealWith Kite, Gilead will gain cancer therapies and experimental drugs in one of the most promising fields in oncology, in addition to its hep...28 Aug, 2017, 11.38 PM IST
- Glenmark anti-myeloma drug gets clinical trial nod from USFDAThis is Glenmark's second investigational new drug from its immuno-oncology portfolio to enter clinical trials.16 May, 2017, 11.43 AM IST
- Medical breakthrough! Aurigene closer to developing cancer treatment capsuleThe Bengaluru-based company is an independent subsidiary of Dr Reddy’s Laboratories and its United States-based partner Curis Inc.01 Jul, 2016, 06.50 AM IST
- Ratan Tata invests in cancer therapeutic startup Invictus OncologyThe startup utilises a supramolecular technology platform to design anti-cancer drugs that home into the tumor and modulate the tumor immun...09 Feb, 2016, 05.06 PM IST
- Merck KGaA bets on cancer drugs to revitalise German firmMerck KGaA is betting on its oncology pipeline to revitalise the German drugmaker as it sees falling sales from its best-selling medicine, ...12 Oct, 2015, 03.49 PM IST
- German drug maker Merck KGaA finds Indian market promising for its pharma, consumer health businessMerck KGaA, the family-controlled $12.5-billion German drug maker, has identified India as one of its key markets under aglobal expansion s...04 Aug, 2015, 04.00 AM IST
- Transgene Biotek gets US patent for liver cancer moleculeBiotechnology firm Transgene Biotek has received patent in the US for its novel molecule to be developed for treatment of liver cancer06 Jul, 2015, 04.27 PM IST
- New drug could potentially treat lung cancerThe drug has shown early potential as an effective treatment for non-small cell lung cancer, the leading cause of cancer death worldwide.04 Nov, 2013, 03.20 PM IST
- Natco Pharmaceuticals inks pact with Swiss firm Chemo Sa Lugano for purchase of drug ingredientsNatco Pharmaceuticals said it has entered into an agreement with Mabxience to purchase four ingredients that will be used in finished drugs.18 Oct, 2011, 04.08 PM IST
Load More
